Newsletter

347850 - D & D Pharmatech, Inc.

347850 Summary
Biopharma
Stock Price & Overview
₩49,200 +700 (+1.44%) Close · Sep 4, 2026 KST
KOSDAQ | ₩KRW | Close: ₩49,200  ≈ US$35  ·  Market cap ₩2.3tn (≈ $1.6bn)
Home › 347850 › Filings

Conversion rights exercised

DART
D & D Pharmatech, Inc.
Filed Jun 22, 2026 KST · Filing · receipt 20260622900667

kstock has not written this one up. The title above is a translation of the Korean form name; the filing itself is on DART, in Korean.

Read the original on DART ↗ Korean. DART is Korea's electronic disclosure system, run by the Financial Supervisory Service — the filing equivalent of EDGAR.
Korean form name: 전환청구권행사 (제1회차)

347850

Price
₩49,200
Change
+1.44%
Market cap
₩2.3tn
Prev. close
₩48,500
347850 SummaryCompare to Peers

More 347850 filings

Material matter affecting investment judgment (clinical trial result)

08/21/26

Half-Year Report

08/14/26

Single Supply Contract Signed

07/14/26

Repurchase of its own convertible bonds before maturity

06/15/26

5% Ownership Report — Large Holdings

06/11/26

Investor Relations Event

06/10/26